Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264,351,875
Number of holders
27
Total 13F shares, excl. options
11,912,678
Shares change
-2,391,339
Total reported value, excl. options
$10,125,354
Value change
-$4,196,499
Number of buys
6
Number of sells
-13
Price
$0.85

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2024

36 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q4 2024.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,912,678 shares of 264,351,875 outstanding shares and own 4.51% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (5,980,568 shares), MORGAN STANLEY (3,543,384 shares), SG Americas Securities, LLC (475,862 shares), TWO SIGMA ADVISERS, LP (430,800 shares), TWO SIGMA INVESTMENTS, LP (330,206 shares), EDBI Pte Ltd (222,136 shares), abrdn plc (162,580 shares), CANTOR FITZGERALD, L. P. (140,100 shares), BNP PARIBAS FINANCIAL MARKETS (109,209 shares), and UBS Group AG (103,054 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.